Stay updated on DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma
Sign up to get notified when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.

Latest updates to the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page
- Check7 days agoChange DetectedDeleted mentions of 'Multiple myeloma' and the 'MedlinePlus Genetics' related topics. The page loses explicit disease context and a related resources link.SummaryDifference0.2%

- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed the older v3.4.1 and funding notices; these are minor site maintenance updates that do not affect study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page adds a government funding notice with operating status information and updates the revision tag to v3.4.1, replacing the previous v3.4.0 entry.SummaryDifference0.4%

- Check28 days agoChange DetectedThe updates are minor, including a UI option to show glossary and small wording/caption changes in QC metadata that do not affect core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedAdded related topic references for 'Multiple myeloma' and a MedlinePlus Genetics link to the related topics section; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision tag updated to v3.3.4 and related topic tags including Multiple myeloma and MedlinePlus Genetics were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma
Enter your email address, and we'll notify you when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.